First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccination at 3, 5, 12 months and 5 years of age

Vaccine(2017)

引用 6|浏览26
暂无评分
摘要
•Three adjuvanted reduced dose IPV-Al SSI were safe and immunogenic in adolescents.•The three IPV-Al SSI were highly immunogenic, but inferior to IPV Vaccine SSI as a booster.•Reduced dose IPV-Al SSI is intended for markets in need of affordable IPV.
更多
查看译文
关键词
Affordable IPV,IPV dose sparing,Dose investigation,Aluminium hydroxide adjuvant
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要